GSK’s Additional Indication Of Botox For Axillary Hyperhidrosis Approved
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline attained approval for Botox injections (botulimum toxin type A) in the treatment of axillary hyperhidrosis, the company announced Nov. 21.